Exane Derivatives’s Beyond Meat BYND Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
$7.4K Sell
309
-2,002
-87% -$64K ﹤0.01% 395
2022
Q1
$112K Sell
2,311
-235
-9% -$12.9K 0.03% 455
2021
Q4
$166K Sell
2,546
-451
-15% -$38.4K 0.04% 368
2021
Q3
$315K Buy
2,997
+466
+18% +$57K 0.08% 277
2021
Q2
$345K Sell
2,531
-856
-25% -$114K 0.08% 255
2021
Q1
$441K Buy
3,387
+207
+7% +$30.4K 0.13% 163
2020
Q4
$397K Buy
+3,180
New +$480K 0.12% 201

Other funds holding BYND

Exane Derivatives's BYND Position: Q2 2022 in Review

Exane Derivatives reduced its Beyond Meat (BYND) stake by 87% in Q2 2022, selling an estimated $64K and leaving 309 shares worth $7.4K. The position accounts for ﹤0.01% of the portfolio, ranked #395.

Exane Derivatives first reported a position in BYND in Q4 2020 and has held it in 7 quarters since. The position peaked at $441K in Q1 2021. 304 funds tracked by Wall St. Rank hold BYND as of Q2 2022.

  • Exane Derivatives held 309 shares of Beyond Meat worth $7.4K as of Q2 2022.
  • Exane Derivatives sold 2,002 Beyond Meat shares in Q2 2022, an estimated $64K.
  • Beyond Meat made up ﹤0.01% of Exane Derivatives's portfolio in Q2 2022, its #395 holding.
  • Exane Derivatives first reported a position in Beyond Meat in Q4 2020 and has held it in 7 quarters since.
  • Exane Derivatives's Beyond Meat position peaked at $441K in Q1 2021.
  • 304 funds tracked by Wall St. Rank held Beyond Meat as of Q2 2022.

Based on Exane Derivatives's 13F filing for Q2 2022, filed 12 Jul 2022.